Outcomes of patients with acute coronary syndromes who are treated with bivalirudin during percutaneous coronary intervention: an analysis from the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE-2) trial.
暂无分享,去创建一个
E. Topol | W. Desmet | V. Rajagopal | A. Lincoff | H. Gurm | J. Bittl | N. Kleiman | D. Cohen | F. Feit | T. Hu | D. Cohen | David J. Cohen | Neal S. Kleiman | E. J. Topol | J. A. Bittl | Walter Desmet